C07D 231/42
Benzene-sulfonamido pyrazoles
C07D231/42 (Benzene-sulfonamido pyrazoles) appears on 53 US grants and 65 published applications in this corpus.
Search patents in C07D- Granted patents
- 53
- Published applications
- 65
- Assignees
- 60
- Inventors
- 277
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 3 |
| 2003 | 1 | 2 |
| 2004 | 1 | 2 |
| 2005 | 2 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 1 |
| 2008 | 2 | 3 |
| 2009 | 2 | 2 |
| 2010 | 2 | 3 |
| 2011 | 1 | 3 |
| 2012 | 6 | 3 |
| 2013 | 3 | 5 |
| 2014 | 3 | 3 |
| 2015 | 4 | 5 |
| 2016 | 3 | 5 |
| 2017 | 2 | 0 |
| 2018 | 4 | 2 |
| 2019 | 2 | 3 |
| 2020 | 1 | 3 |
| 2021 | 0 | 1 |
| 2022 | 1 | 4 |
| 2023 | 2 | 4 |
| 2024 | 1 | 3 |
| 2025 | 1 | 1 |
| 2026 | 4 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides28 Apr 2026US 12,611,404 B2ChemoCentryx, Inc.
- WDR5-MYC inhibitors10 Feb 2026US 12,545,649 B2Vanderbilt University
- Compounds with copper- or zinc-activated toxicity against microbial infection27 Jan 2026US 12,534,440 B2Kansas State University Research Foundation
- Substituted pyridine derivatives as SARM1 inhibitors2 Sep 2025US 12,404,265 B2Nura Bio, Inc.
- Neutrophil elastase inhibitor and use thereof16 Jul 2026US 2026/0200845 A1Shanghai Yidi Biotechnology Co., Ltd
- Inducers of integrated stress response to treat cancer14 Aug 2025US 2025/0257041 A1Board of Regents, The University of Texas System
- Usp30 inhibitors and uses thereof8 Aug 2024US 2024/0262792 A1Vincere Biosciences, Inc.
- Substituted pyridine derivatives as sarm1 inhibitors11 Apr 2024US 2024/0116901 A1Nura Bio, Inc.
- Modulators of fpr1 and methods of using the same18 Jan 2024US 2024/0018124 A1Biofront Ltd
Most cited
By later US patents
- Nitrogen containing heteroaromatics as factor Xa inhibitors211US 6,020,357 ADuPont Pharmaceuticals Company · 2000
- N-(1-arylpyrazol-4L)sulfonamides and their use as parasiticides81US 7,803,832 B2Pfizer Inc. · 2010
- Substituted biphenyl isoxazole sulfonamides70US 5,846,990 ABristol-Myers Squibb Company · 1998
- Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them27US 6,335,334 B12002
- Small molecule inhibitors of the pleckstrin homology domain and methods for using same17US 8,420,678 B2Arizona Board of Regents on Behalf of the University of Arizona · 2013